Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Bauknecht, T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wagner, U; Kohler, S; Reinartz, S; Giffels, P; Huober, J; Renke, K; Schlebusch, H; Biersack, HJ; Mobus, V; Kreienberg, R; Bauknecht, T; Krebs, D; Wallwiener, D
      Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: Immune responses and survival in palliative treatment

      CLINICAL CANCER RESEARCH
    2. Ulrich, U; Rhiem, K; Schmolling, J; Flaskamp, C; Paffenholz, I; Salzer, H; Bauknecht, T; Schlebusch, H
      Cross-linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer

      ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    3. Meinhold-Heerlein, I; Ninci, E; Ikenberg, H; Brandstetter, T; Ihling, C; Schwenk, I; Straub, A; Schmitt, B; Bettendorf, H; Iggo, R; Bauknecht, T
      Evaluation of methods to detect p53 mutations in ovarian cancer

      ONCOLOGY
    4. Brandstetter, T; Ninci, E; Bettendorf, H; Perewusnyk, G; Stolte, J; Herchenbach, D; Sellin, D; Wagner, E; Kochli, OR; Bauknecht, T
      Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferation

      CANCER
    5. Meinhold-Heerlein, I; Stenner-Liewen, F; Liewen, H; Kitada, S; Krajewska, M; Krajewski, S; Zapata, JM; Monks, A; Scudiero, DA; Bauknecht, T; Reed, JC
      Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer

      AMERICAN JOURNAL OF PATHOLOGY
    6. Ressing, ME; van Driel, WJ; Brandt, RMP; Kenter, GG; de Jong, JH; Bauknecht, T; Fleuren, GJ; Hoogerhout, P; Offringa, R; Sette, A; Celis, E; Grey, H; Trimbos, BJ; Kast, WM; Melief, CJM
      Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma

      JOURNAL OF IMMUNOTHERAPY
    7. Ninci, EB; Brandstetter, T; Meinhold-Heerlein, I; Bettendorf, H; Sellin, D; Bauknecht, T
      G-CSF receptor expression in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    8. Bauknecht, T
      Caelyx (R) in the treatment of advanced ovarian cancer

      ONKOLOGIE
    9. du Bois, A; Luck, HJ; Bauknecht, T; Pfisterer, J; Meier, W
      Second-line chemotherapie after platinum or platinum and paclitaxel-based chemotherapy for ovarian cancer: A systematic review

      GEBURTSHILFE UND FRAUENHEILKUNDE
    10. van Driel, WJ; Ressing, ME; Kenter, GG; Brandt, RMP; Krul, EJT; van Rossum, AB; Schuuring, E; Offringa, R; Bauknecht, T; Tamm-Hermelink, A; van Dam, PA; Fleuren, GJ; Kast, WM; Melief, CJM; Trimbos, JB
      Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: Clinical evaluation of a phase I-II trial

      EUROPEAN JOURNAL OF CANCER
    11. du Bois, A; Schlaich, M; Luck, HJ; Mollenkopf, A; Wechsel, U; Rauchholz, M; Bauknecht, T; Meerpohl, HG
      Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

      SUPPORTIVE CARE IN CANCER
    12. von Minckwitz, G; Bauknecht, T; Visseren-Grul, CM; Neijt, JP
      Phase II study of gemcitabine in ovarian cancer

      ANNALS OF ONCOLOGY
    13. du Bois, A; Luck, HJ; Bauknecht, T; Meier, W; Richter, B; Kuhn, W; Quaas, J; Pfisterer, J
      First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: A phase I/II study of the Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group

      JOURNAL OF CLINICAL ONCOLOGY
    14. du Bois, A; Luck, HJ; Bauknecht, T
      First-line chemotherapy in advanced ovarian cancer: State of the art and future aspects

      ONKOLOGIE
    15. Bauknecht, T
      Gene therapy approaches in gynecological oncology

      ONKOLOGIE
    16. Bauknecht, T; Randelzhofer, B; Schmitt, B; Ban, Z; Hernando, JJ; Bauknecht, T
      Response to IL-6 of HPV-18 cervical carcinoma cell lines

      VIROLOGY
    17. VONMINCKWITZ G; KUHN W; THOMSSEN G; UNTCH M; BAUKNECHT T; EIDTMANN D; MOBUS V; DUBOIS A; LUCK HJ
      PHASE-III TRIAL COMPARING EPIRUBICIN PACLITAXEL VS EPIRUBICIN/CYCLOPHOSPHAMID AS FIRST LINE TREATMENT IN METASTATIC BREAST-CANCER - PRELIMINARY-RESULTS OF A GERMAN AGO TRIAL/

      European journal of cancer
    18. MROSS K; HAUNS B; HARING B; BAUKNECHT T; MEERPOHL HG; UNGER C; MAIERLENZ H
      CLINICAL-PHASE-I STUDY WITH ONE-HOUR PACLITAXEL INFUSION

      Annals of oncology
    19. BAUKNECHT T
      ROLE OF GEMCITABINE IN OVARIAN-CANCER

      Annals of oncology
    20. MOBUS V; SCHODER W; LUCK HJ; MEIER W; RICHTER B; WARM M; COSTA S; BAUKNECHT T; OLBRICHT S; NITZ U; JACKISCH C; DUBOIS A
      CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN OVARIAN-CANCER - AN AGO STUDY-GROUP PHASE-III TRIAL/

      Annals of oncology
    21. MEINHOLDHEERLEIN I; BRANDSTETTER T; KOMMOSS F; BETTENDORF H; HAGEDORN M; BAUKNECHT T
      LOCALIZATION OF CYTOKERATIN-10 MESSENGER-RNA IN HUMAN EPIDERMIS USINGNONRADIOACTIVE IN-SITU HYBRIDIZATION AS A ROUTINE METHOD

      Archives of dermatological research
    22. BAUKNECHT T; SHI Y
      OVEREXPRESSION OF C EBP-BETA REPRESSES HUMAN-PAPILLOMAVIRUS TYPE-18 UPSTREAM REGULATORY REGION ACTIVITY IN HELA-CELLS BY INTERFERING WITH THE BINDING OF TATA-BINDING PROTEIN/

      Journal of virology
    23. BRANDSTETTER T; NINCI E; FALKEN U; WAGNER E; HESS R; BAUKNECHT T
      RHG-CSF AFFECTS GENES INVOLVED IN MITOGEN SIGNALING AND EARLY GENE-EXPRESSION IN THE OVARIAN-CANCER CELL-LINE HEY

      International journal of cancer
    24. BRANDSTETTER T; NINCI E; KECK C; BAUKNECHT T; BRECKWOLDT M
      IMPORTANCE OF THE RECEPTOR AND SIGNAL-TRA NSDUCTION OF THE GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN CARCINOMA OF THE OVARY

      Geburtshilfe und Frauenheilkunde
    25. MOBUS V; JACKISCH C; LUCK HJ; MEIER W; BAUKNECHT T; COSTA S; RICHTER B; NITZ U; DUBOIS A
      CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL - OPTIMIZING OF TREATMENT IN ADVANCED OVARIAN-CANCER/

      European journal of cancer
    26. BAUKNECHT T; LUECK HJ; CALVERT H; KREIENBERG R; PASTOVIC R
      TOPOTECAN - A COMPASSIONATE USE STUDY IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER REFRACTORY TO OTHER THERAPIES

      European journal of cancer
    27. BAUKNECHT T
      GENETIC AND CYTOGENETIC ALTERATIONS IN OVARIAN-CANCER

      European journal of cancer
    28. MROSS K; HARING B; HAUNS B; MAIERLENZ H; BAUKNECHT T; MEERPOHL HG; DIERGARTEN K; UNGER C
      CLINICAL AND PHARMACOKINETIC PHASE-I STUDY WITH TAXOL(R) GIVEN AS SHORT 1-HOUR INTRAVENOUS-INFUSION

      European journal of cancer
    29. DUBOIS A; LUCK HJ; BAUKNECHT T; MOBUS V; BOCHTLER H; DIERGARTEN K; MEERPOHL HG
      PHASE-I PHASE-II STUDY OF THE COMBINATION OF CARBOPLATIN AND PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER/

      Annals of oncology
    30. SCHWARZROEGER U; PETZOLDT B; WALDSCHMIDT R; WALKER RP; BAUKNECHT T; KIECHLE M
      UGP - A TUMOR-MARKER OF GYNECOLOGIC AND BREAST MALIGNANCIES - SPECIFICITY AND SENSITIVITY IN PRETHERAPEUTIC PATIENTS AND THE INFLUENCE OF HORMONAL SUBSTITUTION ON THE EXPRESSION OF UGP

      Anticancer research
    31. MAIERLENZ H; HAUNS B; HAERING B; KOETTING J; MROSS K; UNGER C; BAUKNECHT T; DUBOIS A; MEERPOHL HG; HOLLAENDER N; DIERGARTEN K
      PHASE-I STUDY OF PACLITAXEL ADMINISTERED AS A 1-HOUR IN FUSION - TOXICITY AND PHARMACOKINETICS

      Seminars in oncology
    32. DUBOIS A; LUCK HJ; MEIER W; MOBUS V; COSTA S; RICHTER B; WARM M; BAUKNECHT T; SCHRODER W; OLBRICHT S; NITZ U; JACKISCH C
      CARBOPLATIN PACLITAXEL VERSUS CISPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - AN INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL OF THE ARBEITSGEMEINSCHAFT GYNAKOLOGISCHE-ONKOLOGIE OVARIAN-CANCER STUDY-GROUP/

      Seminars in oncology
    33. DUBOIS A; LUCK HJ; MEIER W; MOBUS V; COSTA S; RICHTER B; BAUKNECHT T; WARM M; SCHROEDER W; OLBRICHT S; NITZ U; JACKISCH C
      CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED OVARIAN-CANCER

      Seminars in oncology
    34. MEERPOHL HG; DUBOIS A; LUCK HJ; KUHNLE H; MOBUS V; KREIENBERG R; BAUKNECHT T; KOCHLI O; BOCHTLER H; DIERGARTEN K
      PACLITAXEL COMBINED WITH CARBOPLATIN IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - A PHASE-I TRIAL

      Seminars in oncology
    35. BAUKNECHT T
      MECHANISMS OF CYTOSTATIC RESISTANCE IN OV ARIAN-CANCER

      Geburtshilfe und Frauenheilkunde
    36. BRANDSTETTER T; NINCI E; MAIER G; WAGNER E; BAUKNECHT T
      G-CSF-DEPENDENT EFFECTS ON CELL-CYCLE REGULATION AND P53 ACCUMULATIONIN OVARIAN-CANCER CELLS

      Molecular biology of the cell
    37. ARNOLD N; HAGELE L; WALZ L; SCHEMPP W; PFISTERER J; BAUKNECHT T; KIECHLE M
      OVERREPRESENTATION OF 3Q AND 8Q MATERIAL AND LOSS OF 18Q MATERIAL ARERECURRENT FINDINGS IN ADVANCED HUMAN OVARIAN-CANCER

      Genes, chromosomes & cancer
    38. PREUSS I; HAAS S; EICHHORN U; EBERHAGEN I; KAUFMANN M; BECK T; EIBL RH; DALL P; BAUKNECHT T; HENGSTLER J; WITTIG BM; DIPPOLD W; KAINA B
      ACTIVITY OF THE DNA-REPAIR PROTEIN O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN TUMOR AND CORRESPONDING NORMAL TISSUE

      Cancer detection and prevention
    39. BAUKNECHT T; SEE RH; SHI Y
      A NOVEL C EBP BETA-YY1 COMPLEX CONTROLS THE CELL-TYPE-SPECIFIC ACTIVITY OF THE HUMAN PAPILLOMAVIRUS TYPE-18 UPSTREAM REGULATORY REGION/

      Journal of virology
    40. DALL P; HEKELE A; IKENBERG H; GOPPINGER A; BAUKNECHT T; PFLEIDERER A; MOLL J; HOFMANN M; PONTA H; HERRLICH P
      INCREASING INCIDENCE OF CD44V7 8 EPITOPE EXPRESSION DURING UTERINE CERVICAL CARCINOGENESIS/

      International journal of cancer
    41. SCHAFER CA; DUBOIS A; VACH W; PROMPELER H; BAUKNECHT T; BRECKWOLDT M
      ALTERATIONS OF SEROTONIN METABOLISM IN PR EECLAMPSIA

      Geburtshilfe und Frauenheilkunde
    42. KOMMOSS F; KIECHLESCHWARZ M; DUBOIS A; PFISTERER J; SPINNER D; MADJAR H; BAUKNECHT T; PFLEIDERER A; KACINSKI BM
      COCULTIVATION OF OVARIAN-CARCINOMA CELLS WITH DERMAL FIBROBLASTS INDUCES FIBROBLAST EXPRESSION OF SEX STEROID-RECEPTOR TRANSCRIPTS AND PROTEIN

      International journal of gynecological cancer
    43. KLAASSEN U; KUHNDEL K; BAUKNECHT T; KUHNLE H; JACKISCH C; JONAT W; SCHULZE R; KAUFMANN M; MEIER W; VAHRSON H; WEISS J; WIEST W; URBANCZYK H; HERRMANN F; SCHILLER S; BALTZER J; JANICKE F; MOSNY DS; HECKER D; DIERGARTEN K
      SAFETY AND EFFICACY OF TAXOL(R) (PACLITAXEL) OVER 3 H IN 306 PLATINUM-REFRACTORY PATIENTS WITH OVARIAN-CANCER - RESULTS OF A GERMAN COOPERATIVE STUDY

      European journal of cancer
    44. PFLEIDERER A; BAUKNECHT T
      ENDOMETRIAL CARCINOMA SURGERY - NEW APPRO ACHES AND THOUGHTS ON SURGERY

      Archives of gynecology and obstetrics
    45. JUNDT F; HERR I; ANGEL P; ZURHAUSEN H; BAUKNECHT T
      TRANSCRIPTIONAL CONTROL OF HUMAN PAPILLOMAVIRUS TYPE-18 ONCOGENE EXPRESSION IN DIFFERENT CELL-LINES - ROLE OF TRANSCRIPTION FACTOR YY1

      Virus genes
    46. KIECHLESCHWARZ M; BAUKNECHT T; SCHMIDT J; WALZ L; PFLEIDERER A
      RECURRENT CYTOGENETIC ABERRATIONS IN HUMAN OVARIAN CARCINOMAS

      Cancer detection and prevention
    47. MEERPOHL HG; DUBOIS A; KUHNLE H; LUCK HJ; KREIENBERG R; MOBUS V; BAUKNECHT T; KOCHLI O; BOCHTLER H; DIERGARTEN K; HEUSER A
      PACLITAXEL COMBINED WITH CARBOPLATIN IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER

      Seminars in oncology
    48. BAUKNECHT T; JUNDT F; HERR I; OEHLER T; DELIUS H; SHI Y; ANGEL P; ZURHAUSEN H
      A SWITCH REGION DETERMINES THE CELL-TYPE-SPECIFIC POSITIVE OR NEGATIVE ACTION OF YY1 ON THE ACTIVITY OF THE HUMAN PAPILLOMAVIRUS TYPE-18 PROMOTER

      Journal of virology
    49. SPINNER DM; BRANDSTETTER T; KIECHLESCHWARZ M; DUBOIS A; ANGEL P; BAUKNECHT T
      C-JUN EXPRESSION AND GROWTH-STIMULATION IN HUMAN OVARIAN-CARCINOMA CELL-LINES FOLLOWING EXPOSURE TO CYTOKINES

      International journal of cancer
    50. DUBOIS A; SCHAFER CA; VACH W; PROMPELER H; BAUKNECHT T; BRECKWOLDT M
      INFLUENCE OF PREGNANCY AND DELIVERY ON SE ROTONIN METABOLISM

      Geburtshilfe und Frauenheilkunde
    51. IKENBERG H; MATTHAY K; SCHMITT B; BAUKNECHT T; KIECHLESCHWARZ M; GOPPINGER A; PFLEIDERER A
      P53 MUTATION AND MDM2 AMPLIFICATION ARE RARE EVEN IN HUMAN PAPILLOMAVIRUS-NEGATIVE CERVICAL CARCINOMAS

      Cancer
    52. BAUKNECHT T; KIECHLESCHWARZ M; DUBOIS A; WOLFLE J; KACINSKI B
      EXPRESSION OF TRANSCRIPTS FOR CSF-1 AND FOR THE MACROPHAGE AND EPITHELIAL ISOFORMS OF THE CSF-1R TRANSCRIPTS IN HUMAN OVARIAN CARCINOMAS

      Cancer detection and prevention
    53. MADJAR H; PROMPELER H; WOLFAHRT R; BAUKNECHT T; PFLEIDERER A
      COLOR DOPPLER FLOW DATA OF CARCINOMAS OF THE BREAST

      Ultraschall in der Medizin
    54. DUBOIS A; MEERPOHL HG; MADJAR H; SPINNER D; DALL P; PFISTERER J; BAUKNECHT T
      PHASE-II STUDY OF PIRARUBICIN COMBINED WITH CISPLATIN IN RECURRENT OVARIAN-CANCER

      Journal of cancer research and clinical oncology
    55. KIECHLESCHWARZ M; BAUKNECHT T; KARCK U; KOMMOSS F; DUBOIS A; PFLEIDERER A
      RECURRENT CYTOGENETIC ABERRATIONS AND LOSS OF CONSTITUTIONAL HETEROZYGOSITY IN OVARIAN CARCINOMAS

      Gynecologic oncology
    56. KOMMOSS F; WOLFLE J; BAUKNECHT T; PFISTERER J; KIECHLESCHWARZ M; PFLEIDERER A; SAUERBREI W; KIEHL R; KACINSKI BM
      COEXPRESSION OF M-CSF TRANSCRIPTS AND PROTEIN, FMS (M-CSF RECEPTOR) TRANSCRIPTS AND PROTEIN, AND STEROID-RECEPTOR CONTENT IN ADENOCARCINOMAS OF THE OVARY

      Journal of pathology
    57. BAUKNECHT T
      ADJUVANT MEASURES FOLLOWING PRIMARY SURGE RY OF OVARIAN-CANCER

      Der Gynakologe
    58. BAUKNECHT T; KIECHLESCHWARZ M; KOMMOSS F; WOLFLE J; BIRMELIN G; ANGEL P
      OVARIAN ADENOCARCINOMAS EXPRESS MEMBERS OF DIFFERENT CYTOKINE PATHWAYS - ANALYSIS AND QUANTIFICATION OF TRANSCRIPTS FROM THE TGF-ALPHA AND M-CSF FMS PATHWAYS AND THE TRANSCRIPTION FACTOR CJUN

      International journal of oncology
    59. BERMELIN G; GISE E; BAUKNECHT T; MADJAR H; PFEIDERER A
      ANGIOGENESIS IN BREAST-CANCER - COMPARISO N OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR WITH PROGNOSTIC CRITERIA OF MAMMARY-CARCINOMA

      Archives of gynecology and obstetrics
    60. KIECHLESCHWARZ M; BAUKNECHT T; SCHMIDT J; WALTZ L; PFLEIDERER A
      GENETIC CHANGES IN OVARIAN-CANCER

      Archives of gynecology and obstetrics
    61. BAUKNECHT T; BIRMELIN G; KIECHLESCHWARZ M
      ONCOGENE AND GROWTH-FACTOR EXPRESSION IN OVARIAN-CANCER

      Archives of gynecology and obstetrics
    62. KIECHLESCHWARZ M; BAUKNECHT T; WIENKER T; WALZ L; PFLEIDERER A
      LOSS OF CONSTITUTIONAL HETEROZYGOSITY ON CHROMOSOME-11P IN HUMAN OVARIAN-CANCER - POSITIVE CORRELATION WITH GRADE OF DIFFERENTIATION

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 21:00:03